Hims & Hers (HIMS) has continued their sell-off after my latest article on the company in December 2025. Saturday morning news surfaced that Novo Nordisk (NVO) and HIMS are once again eyeing a partnership Hims & Hers (HIMS) has continued their sell-off after my latest article on the company in December 2025. Saturday morning news surfaced that Novo Nordisk (NVO) and HIMS are once again eyeing a partnership Analyst’s Disclosure: I/we have a beneficial long position in the shares of HIMS, NVO either through stock ownership, options, or other derivatives. I wrote this article myself, and it expre
Hims & Hers (HIMS) has continued their sell-off after my latest article on the company in December 2025. Saturday morning news surfaced that Novo Nordisk (NVO) and HIMS are once again eyeing a partnership Hims & Hers (HIMS) has continued their sell-off after my latest article on the company in December 2025. Saturday morning news surfaced that Novo Nordisk (NVO) and HIMS are once again eyeing a partnership Analyst’s Disclosure: I/we have a beneficial long position in the shares of HIMS, NVO either through stock ownership, options, or other derivatives. I wrote this article myself, and it expre